As per this study, the Global Blood Screening Market was valued USD 3.83 BN (by revenue) in 2022 and is anticipated to reach USD 7.86 BN by 2030 with a CAGR of 9.4%.
Blood screening is a medical process performed in a laboratory where a donor's blood is tested for various infections. Blood screening is performed prior to blood donation in order to check for infected blood before transfusion. The common blood screening tests are blood group or type, HIV, and pregnancy. Further, blood screening helps to monitor diseases and other viral infections.
Market Dynamics
The rising prevalence of infectious diseases and increasing awareness regarding blood donations is propelling the global blood screening market growth. Also, raising awareness among people regarding safe blood donation along with the increasing adoption of nucleic acid testing and healthcare is further anticipated to augment the market demand. However, high initial and operating cost and lack of skilled professionals in blood screening can hinder the market growth. Whereas, the adoption of pathogen reduction technology in the blood screening process is expected to stimulate the market over the forecast period.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of blood screening.
Market Segmentation
The broad blood screening market has been sub-grouped into technology and product. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Product & Service
- Reagents & Kits (NAT Reagents & Kits, ELISA Reagents & Kits, Other Reagents & Kits)
- Instruments (Rental Purchase, Outright Purchase)
- Software & Services
By Technology
- Nucleic Acid Test
- ELISA (Chemiluminescent Immunoassays, Fluorescent Immunoassays, Colorimetric Immunoassays)
- Rapid Tests
- Western Blot Assays
- Next-generation Sequencing
By End User
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for blood screening in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Blood Screening Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Blood Screening market include F. Hoffmann-La Rocher Ltd. (Switzerland), Grifols (Spain), Abbott Laboratories Inc. (US), bioMérieux (France), Bio-Rad Laboratories Inc. (US). An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.